GRI
GRI Bio, Inc.
Nasdaq Pharmaceutical Preparations
Emerging growth company

Key Financials

Net Income
$-11956000
↓ 45.7%
Revenue
$0
↓ 100.0%
Total Assets
$8.7M
↑ 51.0%
Operating Income
$-11977000
↓ 45.4%
EPS (Diluted)
$-121.80
↓ 120.6%
Shareholders' Equity
$6.0M
↑ 49.0%
Cash & Equivalents
$8.2M
↑ 63.7%
Total Liabilities
$2.7M
↑ 55.7%

Recent SEC Filings

Form Type Filed Date Link
8-K 5/14/2026 View on SEC
SCHEDULE 13G/A 5/13/2026 View on SEC
10-Q 5/13/2026 View on SEC
SCHEDULE 13G/A 2/13/2026 View on SEC
SCHEDULE 13G/A 2/10/2026 View on SEC
8-K 2/4/2026 View on SEC
EFFECT 1/30/2026 View on SEC
CORRESP 1/30/2026 View on SEC
UPLOAD 1/30/2026 View on SEC
10-K 1/30/2026 View on SEC

Company Information

Field Value
Ticker GRI
Company Name GRI Bio, Inc.
CIK 1824293
Sector Pharmaceutical Preparations
Industry
Emerging growth company
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone (619) 400-1171